Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Exosomal microRNAs and other non-coding RNAs as colorectal cancer biomarkers: a review

A. Francavilla, S. Turoczi, S. Tarallo, P. Vodicka, B. Pardini, A. Naccarati

. 2020 ; 35 (3) : 243-260. [pub] 20200711

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc21012370

Grantová podpora
NV15-27580A MZ0 CEP - Centrální evidence projektů

The circulating human transcriptome, which includes both coding and non-coding RNA (ncRNA) molecules, represents a rich source of potential biomarkers for colorectal cancer (CRC) that has only recently been explored. In particular, the release of RNA-containing extracellular vesicles (EVs), in a multitude of different in vitro cell systems and in a variety of body fluids, has attracted wide interest. The role of RNA species in EVs is still not fully understood, but their capacity to act as a form of distant communication between cells and their higher abundance in association with cancer demonstrated their relevance. In this review, we report the evidence from both in vitro and human studies on microRNAs (miRNAs) and other ncRNA profiles analysed in EVs in relation to CRC as diagnostic, prognostic and predictive markers. The studies so far highlighted that, in exosomes, the most studied category of EVs, several miRNAs are able to accurately discriminate CRC cases from controls as well as to describe the progression of the disease and its prognosis. Most of the time, the in vitro findings support the miRNA profiles detected in human exosomes. The expression profiles measured in exosomes and other EVs differ and, interestingly, there is a variability of expression also among different subsets of exosomes according to their proteic profile. On the other hand, evidence is still limited for what concerns exosome miRNAs as early diagnostic and predictive markers of treatment. Several other ncRNAs that are carried by exosomes, mostly long ncRNAs and circular RNAs, seem also to be dysregulated in CRC. Besides various technical challenges, such as the standardisation of EVs isolation methods and the optimisation of methodologies to characterise the whole spectrum of RNA molecules in exosomes, further studies are needed in order to elucidate their relevance as CRC markers.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21012370
003      
CZ-PrNML
005      
20210507103736.0
007      
ta
008      
210420s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/mutage/gez038 $2 doi
035    __
$a (PubMed)31784760
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Francavilla, Antonio $u Italian Institute for Genomic Medicine (IIGM), c/o IRCCS Candiolo, Candiolo, Turin, Italy
245    10
$a Exosomal microRNAs and other non-coding RNAs as colorectal cancer biomarkers: a review / $c A. Francavilla, S. Turoczi, S. Tarallo, P. Vodicka, B. Pardini, A. Naccarati
520    9_
$a The circulating human transcriptome, which includes both coding and non-coding RNA (ncRNA) molecules, represents a rich source of potential biomarkers for colorectal cancer (CRC) that has only recently been explored. In particular, the release of RNA-containing extracellular vesicles (EVs), in a multitude of different in vitro cell systems and in a variety of body fluids, has attracted wide interest. The role of RNA species in EVs is still not fully understood, but their capacity to act as a form of distant communication between cells and their higher abundance in association with cancer demonstrated their relevance. In this review, we report the evidence from both in vitro and human studies on microRNAs (miRNAs) and other ncRNA profiles analysed in EVs in relation to CRC as diagnostic, prognostic and predictive markers. The studies so far highlighted that, in exosomes, the most studied category of EVs, several miRNAs are able to accurately discriminate CRC cases from controls as well as to describe the progression of the disease and its prognosis. Most of the time, the in vitro findings support the miRNA profiles detected in human exosomes. The expression profiles measured in exosomes and other EVs differ and, interestingly, there is a variability of expression also among different subsets of exosomes according to their proteic profile. On the other hand, evidence is still limited for what concerns exosome miRNAs as early diagnostic and predictive markers of treatment. Several other ncRNAs that are carried by exosomes, mostly long ncRNAs and circular RNAs, seem also to be dysregulated in CRC. Besides various technical challenges, such as the standardisation of EVs isolation methods and the optimisation of methodologies to characterise the whole spectrum of RNA molecules in exosomes, further studies are needed in order to elucidate their relevance as CRC markers.
650    _2
$a nádorové biomarkery $x genetika $x metabolismus $7 D014408
650    _2
$a kolorektální nádory $x krev $x diagnóza $x genetika $x metabolismus $7 D015179
650    _2
$a progrese nemoci $7 D018450
650    _2
$a exozómy $x genetika $x metabolismus $7 D055354
650    _2
$a extracelulární vezikuly $x genetika $x metabolismus $7 D000067128
650    _2
$a lidé $7 D006801
650    _2
$a mikro RNA $x genetika $x metabolismus $7 D035683
650    _2
$a nekódující RNA $x genetika $x metabolismus $7 D022661
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Turoczi, Szimonetta $u Italian Institute for Genomic Medicine (IIGM), c/o IRCCS Candiolo, Candiolo, Turin, Italy
700    1_
$a Tarallo, Sonia $u Italian Institute for Genomic Medicine (IIGM), c/o IRCCS Candiolo, Candiolo, Turin, Italy
700    1_
$a Vodicka, Pavel $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Prague, Czech Republic
700    1_
$a Pardini, Barbara $u Italian Institute for Genomic Medicine (IIGM), c/o IRCCS Candiolo, Candiolo, Turin, Italy
700    1_
$a Naccarati, Alessio $u Italian Institute for Genomic Medicine (IIGM), c/o IRCCS Candiolo, Candiolo, Turin, Italy $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Prague, Czech Republic
773    0_
$w MED00003429 $t Mutagenesis $x 1464-3804 $g Roč. 35, č. 3 (2020), s. 243-260
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31784760 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507103735 $b ABA008
999    __
$a ok $b bmc $g 1650692 $s 1132749
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 35 $c 3 $d 243-260 $e 20200711 $i 1464-3804 $m Mutagenesis $n Mutagenesis $x MED00003429
GRA    __
$a NV15-27580A $p MZ0
LZP    __
$a Pubmed-20210420

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...